| (+)-catechin | multiple interactions | ISO | RGD:1346183 | 6480464 | Catechin results in increased cleavage of and results in increased activity of BID protein | CTD | PMID:20206613 |
| (-)-anisomycin | multiple interactions | ISO | RGD:1346183 | 6480464 | Anisomycin results in increased cleavage of and results in increased activity of BID protein | CTD | PMID:18241849 |
| (R)-mevalonic acid | multiple interactions | ISO | RGD:620160 | 6480464 | Mevalonic Acid inhibits the reaction [atorvastatin results in decreased expression of and results in increased cleavage of BID protein] | CTD | PMID:18339080 |
| 17beta-estradiol | multiple interactions | ISO | RGD:1346183 | 6480464 | Estradiol inhibits the reaction [Etoposide results in increased expression of BID mRNA] | CTD | PMID:19426747 |
| 17beta-estradiol | increases expression | ISO | RGD:1346183 | 6480464 | Estradiol results in increased expression of BID mRNA | CTD | PMID:20106945 |
| 17beta-estradiol | decreases expression | ISO | RGD:1346183 | 6480464 | Estradiol results in decreased expression of BID mRNA | CTD | PMID:19426747 |
| 1H-pyrazole | increases expression | EXP | | 6480464 | pyrazole results in increased expression of BID mRNA | CTD | PMID:17945193 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases cleavage | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased cleavage of BID protein | CTD | PMID:15972635 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | EXP | | 6480464 | Tetrachlorodibenzodioxin affects the expression of BID mRNA | CTD | PMID:21570461 |
| 2,3,7,8-tetrachlorodibenzodioxine | affects expression | ISO | RGD:620160 | 6480464 | Tetrachlorodibenzodioxin affects the expression of BID mRNA | CTD | PMID:22298810 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of BID mRNA | CTD | PMID:15972635 PMID:14718646 |
| 2,3,7,8-tetrachlorodibenzodioxine | increases expression | EXP | | 6480464 | Tetrachlorodibenzodioxin results in increased expression of BID mRNA | CTD | PMID:14718646 PMID:15972635 |
| 2,4-dinitrotoluene | affects expression | ISO | RGD:620160 | 6480464 | 2,4-dinitrotoluene affects the expression of BID mRNA | CTD | PMID:21346803 |
| 2,6-dinitrotoluene | affects expression | ISO | RGD:620160 | 6480464 | 2,6-dinitrotoluene affects the expression of BID mRNA | CTD | PMID:21346803 |
| 2-amino-2-deoxy-D-galactopyranose | multiple interactions | ISO | RGD:620160 | 6480464 | [lipopolysaccharide, Escherichia coli 0111 B4 co-treated with Galactosamine] results in increased cleavage of BID protein | CTD | PMID:12907702 |
| 2-amino-2-deoxy-D-galactopyranose | multiple interactions | ISO | RGD:620160 | 6480464 | [Galactosamine co-treated with Lipopolysaccharides] results in increased expression of BID mRNA | CTD | PMID:21401295 |
| 4,4'-diaminodiphenylmethane | increases expression | EXP | | 6480464 | 4,4'-diaminodiphenylmethane results in increased expression of BID mRNA | CTD | PMID:18648102 |
| 4-hydroxynon-2-enal | increases expression | EXP | | 6480464 | 4-hydroxy-2-nonenal results in increased expression of BID mRNA | CTD | PMID:19191707 |
| 4-hydroxyphenyl retinamide | multiple interactions | ISO | RGD:1346183 | 6480464 | [Fenretinide co-treated with TNFSF10 protein] results in increased cleavage of BID protein | CTD | PMID:17273769 |
| 4-nonylphenol | multiple interactions | EXP | | 6480464 | 4-nonylphenol results in increased cleavage of and results in increased activity of BID protein | CTD | PMID:22056370 |
| 5-aza-2'-deoxycytidine | multiple interactions | ISO | RGD:1346183 | 6480464 | [Valproic Acid co-treated with decitabine] results in increased cleavage of BID protein | CTD | PMID:21771726 |
| 5-fluorouracil | multiple interactions | ISO | RGD:1346183 | 6480464 | BCL2L1 protein inhibits the reaction [BID protein results in increased susceptibility to Fluorouracil] | CTD | PMID:15289866 |
| 5-fluorouracil | multiple interactions | ISO | RGD:1346183 | 6480464 | Fluorouracil results in increased cleavage of and results in increased activity of BID protein; more ... | CTD | PMID:21474236 |
| 5-fluorouracil | decreases response to substance | ISO | RGD:1346183 | 6480464 | BID protein mutant form results in decreased susceptibility to Fluorouracil | CTD | PMID:15095271 |
| 5-fluorouracil | decreases expression | ISO | RGD:1346183 | 6480464 | Fluorouracil results in decreased expression of BID protein | CTD | PMID:15754201 |
| 5-fluorouracil | multiple interactions | ISO | RGD:1346183 | 6480464 | [Fluorouracil co-treated with irinotecan co-treated with vorinostat] results in increased cleavage of BID protein | CTD | PMID:15754201 |
| 5-fluorouracil | increases response to substance | ISO | RGD:1346183 | 6480464 | BID protein results in increased susceptibility to Fluorouracil | CTD | PMID:15289866 |
| 6-formylpterin | decreases expression | ISO | RGD:1346183 | 6480464 | 2-amino-4-hydroxy-6-formylpteridine results in decreased expression of BID protein | CTD | PMID:16019850 |
| acetylsalicylic acid | multiple interactions | ISO | RGD:1346183 | 6480464 | [Aspirin co-treated with TNFSF10 protein] results in increased cleavage of BID protein | CTD | PMID:18483385 |
| acetylsalicylic acid | increases cleavage | ISO | RGD:1346183 | 6480464 | Aspirin results in increased cleavage of BID protein | CTD | PMID:15976387 |
| acetylsalicylic acid | multiple interactions | ISO | RGD:1346183 | 6480464 | CASP8 affects the reaction [Aspirin results in increased cleavage of BID protein] | CTD | PMID:15976387 |
| actinomycin D | multiple interactions | ISO | RGD:1346183 | 6480464 | Dactinomycin inhibits the reaction [vorinostat results in increased cleavage of BID protein] | CTD | PMID:11535817 |
| actinomycin D | multiple interactions | EXP | | 6480464 | Dactinomycin inhibits the reaction [sodium arsenite results in increased expression of BID mRNA] | CTD | PMID:16166651 |
| aflatoxin B1 | increases expression | EXP | | 6480464 | Aflatoxin B1 results in increased expression of BID mRNA | CTD | PMID:19770486 |
| alantolactone | increases cleavage | ISO | RGD:1346183 | 6480464 | alantolactone results in increased cleavage of BID protein | CTD | PMID:22721982 |
| all-trans-retinoic acid | multiple interactions | ISO | RGD:1346183 | 6480464 | [Tretinoin co-treated with Paclitaxel] results in increased cleavage of BID protein | CTD | PMID:18098270 |
| all-trans-retinoic acid | decreases expression | ISO | RGD:1346183 | 6480464 | Tretinoin results in decreased expression of BID protein | CTD | PMID:16242776 |
| amiodarone | multiple interactions | ISO | RGD:1346183 | 6480464 | [TNFSF10 co-treated with Amiodarone] results in increased cleavage of BID protein | CTD | PMID:21292685 |
| ammonium chloride | affects expression | ISO | RGD:620160 | 6480464 | Ammonium Chloride affects the expression of BID mRNA | CTD | PMID:16483693 |
| andrographolide | multiple interactions | ISO | RGD:620160 | 6480464 | andrographolide promotes the reaction [Penicillamine inhibits the reaction [Copper Sulfate results in decreased expression of and results in increased cleavage of BID protein]]; more ... | CTD | PMID:20946909 |
| arachidonic acid | increases cleavage | ISO | RGD:1346183 | 6480464 | Arachidonic Acid results in increased cleavage of BID protein | CTD | PMID:19720122 |
| arachidonic acid | multiple interactions | ISO | RGD:1346183 | 6480464 | FADD protein promotes the reaction [Arachidonic Acid results in increased cleavage of BID protein] | CTD | PMID:19720122 |
| arsenic atom | increases expression | ISO | RGD:1346183 | 6480464 | Arsenic results in increased expression of BID mRNA | CTD | PMID:19945496 |
| azadirachtin A | increases expression | ISO | RGD:1346183 | 6480464 | azadirachtin results in increased expression of BID mRNA | CTD | PMID:20429769 |
| BAPTA | multiple interactions | ISO | RGD:1346183 | 6480464 | 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Diclofenac results in increased activity of BID protein] | CTD | PMID:18191430 |
| benzo[a]pyrene | decreases expression | ISO | RGD:1346183 | 6480464 | Benzo(a)pyrene results in decreased expression of BID protein | CTD | PMID:15698582 |
| benzo[a]pyrene | increases expression | EXP | | 6480464 | Benzo(a)pyrene results in increased expression of BID mRNA | CTD | PMID:22228805 |
| benzo[a]pyrene | decreases expression | EXP | | 6480464 | Benzo(a)pyrene results in decreased expression of BID mRNA | CTD | PMID:19770486 |
| benzo[a]pyrene | multiple interactions | EXP | | 6480464 | [Benzo(a)pyrene co-treated with XPA gene mutant form co-treated with TRP53 gene mutant form] results in decreased expression of BID mRNA | CTD | PMID:21715664 |
| benzo[a]pyrene | multiple interactions | ISO | RGD:1346183 | 6480464 | Nitrogen Oxides inhibits the reaction [Benzo(a)pyrene results in increased expression of BID protein] | CTD | PMID:16041517 |
| benzo[a]pyrene | increases expression | ISO | RGD:1346183 | 6480464 | Benzo(a)pyrene results in increased expression of BID protein | CTD | PMID:16041517 |
| bis(2-chloroethyl) sulfide | increases expression | EXP | | 6480464 | Mustard Gas results in increased expression of BID mRNA | CTD | PMID:18955075 |
| bisphenol A | decreases methylation | ISO | RGD:1346183 | 6480464 | bisphenol A results in decreased methylation of BID gene | CTD | PMID:22576693 |
| bisphenol A | increases expression | ISO | RGD:1346183 | 6480464 | bisphenol A results in increased expression of BID mRNA | CTD | PMID:22576693 |
| brassinolide | decreases expression | ISO | RGD:1346183 | 6480464 | brassinolide results in decreased expression of BID protein | CTD | PMID:20833159 |
| cadmium atom | multiple interactions | ISO | RGD:620160 | 6480464 | Cadmium inhibits the reaction [TNF protein results in increased cleavage of BID protein] | CTD | PMID:16263807 |
| cadmium dichloride | multiple interactions | EXP | | 6480464 | arjunolic acid inhibits the reaction [Cadmium Chloride results in increased expression of BID protein] | CTD | PMID:21420465 |
| cadmium dichloride | increases expression | ISO | RGD:1346183 | 6480464 | Cadmium Chloride results in increased expression of BID | CTD | PMID:21787858 |
| cadmium dichloride | decreases expression | ISO | RGD:1346183 | 6480464 | Cadmium Chloride results in decreased expression of BID mRNA | CTD | PMID:21457566 |
| cadmium dichloride | decreases expression | EXP | | 6480464 | Cadmium Chloride results in decreased expression of BID protein | CTD | PMID:19887573 |
| cadmium dichloride | multiple interactions | ISO | RGD:620160 | 6480464 | Cadmium Chloride inhibits the reaction [TNF protein results in increased cleavage of BID protein] | CTD | PMID:16263807 |
| cadmium dichloride | increases expression | EXP | | 6480464 | Cadmium Chloride results in increased expression of BID protein | CTD | PMID:21420465 |
| caffeine | multiple interactions | ISO | RGD:1346183 | 6480464 | Caffeine inhibits the reaction [silybin results in increased cleavage of BID protein] | CTD | PMID:16777994 |
| camptothecin | multiple interactions | ISO | RGD:1346183 | 6480464 | [Camptothecin co-treated with FAS protein] results in increased cleavage of BID protein | CTD | PMID:19633536 |
| camptothecin | multiple interactions | ISO | RGD:1346183 | 6480464 | [Camptothecin co-treated with 3-(5'-hydroxymethyl-2'-furyl)-1-benzylindazole] results in increased cleavage of and results in decreased expression of BID protein; more ... | CTD | PMID:19481069 |
| capsaicin | multiple interactions | ISO | RGD:1346183 | 6480464 | Capsaicin promotes the reaction [TNFSF10 results in increased cleavage of BID protein] | CTD | PMID:22200406 |
| capsaicin | increases expression | ISO | RGD:1346183 | 6480464 | Capsaicin results in increased expression of BID mRNA | CTD | PMID:19502594 |
| capsaicin | increases cleavage | ISO | RGD:1346183 | 6480464 | Capsaicin results in increased cleavage of BID protein | CTD | PMID:19502594 |
| celecoxib | multiple interactions | ISO | RGD:1346183 | 6480464 | [ABT-737 co-treated with celecoxib] results in increased cleavage of BID protein | CTD | PMID:20104024 |
| celecoxib | multiple interactions | ISO | RGD:1346183 | 6480464 | TNFSF10 protein promotes the reaction [celecoxib results in increased cleavage of BID protein] | CTD | PMID:15572759 |
| celecoxib | increases cleavage | ISO | RGD:1346183 | 6480464 | celecoxib results in increased cleavage of BID protein | CTD | PMID:15197583 |
| chrysazin | increases expression | ISO | RGD:1346183 | 6480464 | danthron results in increased expression of BID protein | CTD | PMID:21126053 |
| ciglitazone | multiple interactions | ISO | RGD:1346183 | 6480464 | DDIT3 mutant form inhibits the reaction [[Niflumic Acid co-treated with ciglitazone] results in increased cleavage of BID protein] | CTD | PMID:21067863 |
| cilostazol | multiple interactions | ISO | RGD:620160 | 6480464 | cilostazol inhibits the reaction [Nitroprusside results in increased cleavage of and results in increased localization of BID protein]; more ... | CTD | PMID:18311796 |
| cisplatin | multiple interactions | ISO | RGD:1346183 | 6480464 | Acetylcysteine inhibits the reaction [[Cisplatin co-treated with FASLG protein] results in decreased expression of BID protein] | CTD | PMID:17574045 |
| cisplatin | increases activity | ISO | RGD:1346183 | 6480464 | Cisplatin results in increased activity of BID protein | CTD | PMID:21527773 PMID:21052098 |
| cisplatin | multiple interactions | ISO | RGD:1346183 | 6480464 | [TNFSF10 protein co-treated with Cisplatin] results in increased cleavage of BID protein | CTD | PMID:21252285 |
| cisplatin | multiple interactions | ISO | RGD:1346183 | 6480464 | Cisplatin inhibits the reaction [CASP8 protein results in increased cleavage of BID protein] | CTD | PMID:19590723 |
| cisplatin | increases expression | EXP | | 6480464 | Cisplatin results in increased expression of BID mRNA | CTD | PMID:21151649 |
| cisplatin | increases activity | ISO | RGD:1346183 | 6480464 | Cisplatin results in increased activity of BID protein | CTD | PMID:21052098 PMID:21527773 |
| cisplatin | multiple interactions | ISO | RGD:1346183 | 6480464 | [Cisplatin co-treated with pemetrexed] results in increased cleavage of BID protein | CTD | PMID:19351772 |
| cisplatin | multiple interactions | ISO | RGD:1346183 | 6480464 | [Cisplatin co-treated with fisetin] results in increased cleavage of BID protein | CTD | PMID:21216935 |
| cobalt dichloride | decreases expression | ISO | RGD:1346183 | 6480464 | cobaltous chloride results in decreased expression of BID mRNA | CTD | PMID:19320972 |
| cocaine | affects expression | EXP | | 6480464 | Cocaine affects the expression of BID mRNA | CTD | PMID:15681117 |
| copper atom | multiple interactions | ISO | RGD:1346183 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of BID mRNA | CTD | PMID:20971185 |
| copper atom | increases cleavage | EXP | | 6480464 | Copper analog results in increased cleavage of BID protein | CTD | PMID:22000994 |
| copper(0) | multiple interactions | ISO | RGD:1346183 | 6480464 | [NSC 689534 binds to Copper] which results in decreased expression of BID mRNA | CTD | PMID:20971185 |
| copper(0) | increases cleavage | EXP | | 6480464 | Copper analog results in increased cleavage of BID protein | CTD | PMID:22000994 |
| copper(2+) sulfate | multiple interactions | ISO | RGD:620160 | 6480464 | andrographolide inhibits the reaction [Copper Sulfate results in decreased expression of and results in increased cleavage of BID protein]; more ... | CTD | PMID:20946909 |
| copper(II) chloride | increases expression | ISO | RGD:1346183 | 6480464 | cupric chloride results in increased expression of BID mRNA | CTD | PMID:17211630 |
| cordycepin | multiple interactions | ISO | RGD:1346183 | 6480464 | Acetylcysteine inhibits the reaction [cordycepin results in decreased expression of BID protein] | CTD | PMID:21310227 |
| cordycepin | decreases expression | ISO | RGD:1346183 | 6480464 | cordycepin results in decreased expression of BID protein | CTD | PMID:21310227 |
| curcumin | multiple interactions | ISO | RGD:1346183 | 6480464 | Curcumin promotes the reaction [arsenic trioxide results in increased activity of BID protein] | CTD | PMID:20605902 |
| cycloheximide | multiple interactions | ISO | RGD:1346183 | 6480464 | Cycloheximide inhibits the reaction [vorinostat results in increased cleavage of BID protein] | CTD | PMID:11535817 |
| cycloheximide | multiple interactions | ISO | RGD:1346183 | 6480464 | [Cycloheximide co-treated with TNF] results in increased cleavage of BID protein; more ... | CTD | PMID:12925536 |
| cyclosporin A | increases expression | ISO | RGD:1346183 | 6480464 | Cyclosporine results in increased expression of BID mRNA | CTD | PMID:20106945 |
| cytarabine | multiple interactions | ISO | RGD:1346183 | 6480464 | [Cytarabine co-treated with TNFSF10 protein] results in increased expression of BID protein | CTD | PMID:12780785 |
| D-penicillamine | multiple interactions | ISO | RGD:620160 | 6480464 | Penicillamine inhibits the reaction [Copper Sulfate results in decreased expression of and results in increased cleavage of BID protein]; more ... | CTD | PMID:20946909 |
| daunorubicin | multiple interactions | ISO | RGD:1346183 | 6480464 | [Daunorubicin co-treated with TNFSF10 protein] results in increased expression of BID protein | CTD | PMID:12780785 |
| DDE | increases cleavage | ISO | RGD:1346183 | 6480464 | Dichlorodiphenyl Dichloroethylene results in increased cleavage of BID protein | CTD | PMID:19545618 |
| diarsenic trioxide | multiple interactions | ISO | RGD:1346183 | 6480464 | arsenic trioxide results in increased cleavage of and results in increased activity of BID protein | CTD | PMID:15665116 more ... |
| diarsenic trioxide | multiple interactions | ISO | RGD:1346183 | 6480464 | [arsenic trioxide co-treated with TNF protein] results in increased cleavage of and results in increased activity of BID protein | CTD | PMID:17673311 |
| diarsenic trioxide | increases cleavage | ISO | RGD:1346183 | 6480464 | arsenic trioxide results in increased cleavage of BID protein | CTD | PMID:10648417 PMID:19364129 |
| diarsenic trioxide | increases activity | ISO | RGD:1346183 | 6480464 | arsenic trioxide results in increased activity of BID protein | CTD | PMID:20605902 |
| diarsenic trioxide | multiple interactions | ISO | RGD:1346183 | 6480464 | Curcumin promotes the reaction [arsenic trioxide results in increased activity of BID protein] | CTD | PMID:20605902 |
| diarsenic trioxide | affects expression | ISO | RGD:620160 | 6480464 | arsenic trioxide affects the expression of BID protein | CTD | PMID:18618274 |
| diarsenic trioxide | multiple interactions | ISO | RGD:1346183 | 6480464 | [arsenic trioxide co-treated with Quercetin] results in increased cleavage of BID protein | CTD | PMID:18359480 |
| diarsenic trioxide | multiple interactions | ISO | RGD:1346183 | 6480464 | [arsenic trioxide co-treated with lonidamine] results in increased cleavage of and results in increased activity of BID protein | CTD | PMID:21889928 |
| diarsenic trioxide | affects cleavage | ISO | RGD:1346183 | 6480464 | arsenic trioxide affects the cleavage of BID protein | CTD | PMID:15131059 |
| diarsenic trioxide | multiple interactions | ISO | RGD:1346183 | 6480464 | arsenic trioxide results in increased cleavage of and results in increased activity of BID protein | CTD | PMID:18546268 more ... |
| diarsenic trioxide | multiple interactions | ISO | RGD:1346183 | 6480464 | arsenic trioxide results in increased cleavage of and results in increased activity of BID protein | CTD | PMID:18546268 more ... |
| diarsenic trioxide | multiple interactions | ISO | RGD:1346183 | 6480464 | arsenic trioxide results in increased cleavage of and results in increased activity of BID protein | CTD | PMID:12851490 more ... |
| diarsenic trioxide | multiple interactions | ISO | RGD:1346183 | 6480464 | TP53 protein inhibits the reaction [arsenic trioxide results in increased cleavage of and results in increased activity of BID protein] | CTD | PMID:12851490 |
| diarsenic trioxide | multiple interactions | ISO | RGD:1346183 | 6480464 | arsenic trioxide results in increased cleavage of and results in increased activity of BID protein | CTD | PMID:15665116 more ... |
| diarsenic trioxide | increases cleavage | ISO | RGD:1346183 | 6480464 | arsenic trioxide results in increased cleavage of BID protein | CTD | PMID:19364129 |
| diarsenic trioxide | multiple interactions | ISO | RGD:1346183 | 6480464 | Genistein promotes the reaction [arsenic trioxide results in increased cleavage of and results in increased activity of BID protein] | CTD | PMID:18546268 |
| diarsenic trioxide | decreases expression | ISO | RGD:1346183 | 6480464 | arsenic trioxide results in decreased expression of BID protein | CTD | PMID:21418039 |
| diarsenic trioxide | multiple interactions | ISO | RGD:1346183 | 6480464 | anthra(1,9-cd)pyrazol-6(2H)-one promotes the reaction [arsenic trioxide results in increased cleavage of BID protein]; more ... | CTD | PMID:16972261 |
| diarsenic trioxide | multiple interactions | ISO | RGD:1346183 | 6480464 | [arsenic trioxide co-treated with esculetin] results in increased cleavage of BID protein | CTD | PMID:19428345 |
| dibutyl phthalate | increases expression | ISO | RGD:620160 | 6480464 | Dibutyl Phthalate results in increased expression of BID mRNA | CTD | PMID:21266533 |
| dibutyl phthalate | decreases expression | EXP | | 6480464 | Dibutyl Phthalate results in decreased expression of BID mRNA | CTD | PMID:21266533 |
| diclofenac | multiple interactions | ISO | RGD:1346183 | 6480464 | 1,2-bis(2-aminophenoxy)ethane-N,N,N',N'-tetraacetic acid inhibits the reaction [Diclofenac results in increased activity of BID protein] | CTD | PMID:18191430 |
| diclofenac | increases activity | ISO | RGD:1346183 | 6480464 | Diclofenac results in increased activity of BID protein | CTD | PMID:18191430 |
| doxorubicin | multiple interactions | ISO | RGD:1346183 | 6480464 | BCL2L1 protein inhibits the reaction [BID protein results in increased susceptibility to Doxorubicin] | CTD | PMID:15289866 |
| doxorubicin | multiple interactions | ISO | RGD:620160 | 6480464 | HMOX1 protein inhibits the reaction [Doxorubicin results in increased phosphorylation of BID protein] | CTD | PMID:18845810 |
| doxorubicin | increases phosphorylation | ISO | RGD:620160 | 6480464 | Doxorubicin results in increased phosphorylation of BID protein | CTD | PMID:18845810 |
| doxorubicin | multiple interactions | ISO | RGD:1346183 | 6480464 | [Indomethacin results in increased cleavage of BID protein] which results in increased susceptibility to Doxorubicin | CTD | PMID:15812552 |
| doxorubicin | decreases expression | ISO | RGD:1346183 | 6480464 | Doxorubicin results in decreased expression of BID mRNA | CTD | PMID:16705698 |
| doxorubicin | affects cleavage | ISO | RGD:1346183 | 6480464 | Doxorubicin affects the cleavage of BID protein | CTD | PMID:15870702 |
| doxorubicin | multiple interactions | ISO | RGD:1346183 | 6480464 | [Doxorubicin co-treated with Phellinus linteus extract] results in increased cleavage of BID protein | CTD | PMID:16868541 |
| doxorubicin | increases response to substance | ISO | RGD:1346183 | 6480464 | BID protein results in increased susceptibility to Doxorubicin | CTD | PMID:15289866 |
| doxorubicin | multiple interactions | ISO | RGD:1346183 | 6480464 | BCL2 protein inhibits the reaction [2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Doxorubicin results in increased cleavage of and results in increased activity of and results in increased localization of BID protein]]; more ... | CTD | PMID:20856197 |
| elemental selenium | increases cleavage | ISO | RGD:1346183 | 6480464 | Selenium results in increased cleavage of BID protein | CTD | PMID:12432279 |
| esculetin | multiple interactions | ISO | RGD:1346183 | 6480464 | [arsenic trioxide co-treated with esculetin] results in increased cleavage of BID protein | CTD | PMID:19428345 |
| etoposide | multiple interactions | ISO | RGD:1346183 | 6480464 | Estradiol inhibits the reaction [Etoposide results in increased expression of BID mRNA] | CTD | PMID:19426747 |
| etoposide | increases expression | ISO | RGD:1346183 | 6480464 | Etoposide results in increased expression of BID mRNA | CTD | PMID:19426747 |
| etoposide | increases cleavage | ISO | RGD:1346183 | 6480464 | Etoposide results in increased cleavage of BID protein | CTD | PMID:21801448 |
| etoposide | multiple interactions | ISO | RGD:1346183 | 6480464 | CASP9 mutant form inhibits the reaction [Etoposide results in increased cleavage of BID protein] | CTD | PMID:21801448 |
| eugenol | multiple interactions | EXP | | 6480464 | Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of BID mRNA] | CTD | PMID:20434464 |
| fisetin | multiple interactions | ISO | RGD:1346183 | 6480464 | [Cisplatin co-treated with fisetin] results in increased cleavage of BID protein | CTD | PMID:21216935 |
| fisetin | increases cleavage | ISO | RGD:1346183 | 6480464 | fisetin results in increased cleavage of BID protein | CTD | PMID:21216935 |
| furosemide | affects expression | ISO | RGD:620160 | 6480464 | Furosemide affects the expression of BID mRNA | CTD | PMID:17497460 |
| genistein | multiple interactions | ISO | RGD:1346183 | 6480464 | Genistein promotes the reaction [arsenic trioxide results in increased cleavage of and results in increased activity of BID protein]; more ... | CTD | PMID:18546268 |
| genistein | multiple interactions | ISO | RGD:1346183 | 6480464 | [Genistein co-treated with TNFSF10 protein] results in increased cleavage of BID protein | CTD | PMID:19497411 |
| hexachlorobenzene | decreases expression | ISO | RGD:620160 | 6480464 | Hexachlorobenzene results in decreased expression of BID protein | CTD | PMID:21787832 |
| hydrogen peroxide | increases expression | ISO | RGD:620160 | 6480464 | Hydrogen Peroxide results in increased expression of BID mRNA | CTD | PMID:14689451 |
| imatinib | multiple interactions | ISO | RGD:1346183 | 6480464 | [imatinib co-treated with flavopiridol] results in increased activity of BID protein; more ... | CTD | PMID:12231544 |
| indomethacin | multiple interactions | ISO | RGD:1346183 | 6480464 | [Indomethacin results in increased cleavage of BID protein] which results in increased susceptibility to Doxorubicin | CTD | PMID:15812552 |
| indomethacin | increases cleavage | ISO | RGD:1346183 | 6480464 | Indomethacin results in increased cleavage of BID protein | CTD | PMID:15812552 |
| isoflurane | decreases expression | ISO | RGD:620160 | 6480464 | Isoflurane results in decreased expression of BID mRNA | CTD | PMID:16978161 |
| lead diacetate | affects expression | ISO | RGD:620160 | 6480464 | lead acetate affects the expression of BID protein | CTD | PMID:18618274 |
| lonidamine | increases activity | ISO | RGD:1346183 | 6480464 | lonidamine results in increased activity of BID protein | CTD | PMID:20605902 |
| lonidamine | multiple interactions | ISO | RGD:1346183 | 6480464 | [arsenic trioxide co-treated with lonidamine] results in increased cleavage of and results in increased activity of BID protein | CTD | PMID:21889928 |
| LY294002 | multiple interactions | ISO | RGD:1346183 | 6480464 | 2-(4-morpholinyl)-8-phenyl-4H-1-benzopyran-4-one promotes the reaction [Doxorubicin results in increased cleavage of and results in increased activity of and results in increased localization of BID protein]; more ... | CTD | PMID:20856197 |
| melatonin | multiple interactions | ISO | RGD:1346183 | 6480464 | Melatonin promotes the reaction [BID protein binds to BAX protein] | CTD | PMID:19552762 |
| melatonin | increases expression | ISO | RGD:1346183 | 6480464 | Melatonin results in increased expression of BID protein | CTD | PMID:19552762 |
| methoxychlor | multiple interactions | EXP | | 6480464 | ESR1 gene mutant form promotes the reaction [Methoxychlor results in increased expression of BID mRNA] | CTD | PMID:22306526 |
| methoxychlor | increases expression | EXP | | 6480464 | Methoxychlor results in increased expression of BID mRNA | CTD | PMID:22306526 |
| mevalonic acid | multiple interactions | ISO | RGD:620160 | 6480464 | Mevalonic Acid inhibits the reaction [atorvastatin results in decreased expression of and results in increased cleavage of BID protein] | CTD | PMID:18339080 |
| mifepristone | increases expression | ISO | RGD:1346183 | 6480464 | Mifepristone results in increased expression of BID mRNA | CTD | PMID:17584828 |
| minocycline | multiple interactions | EXP | | 6480464 | Minocycline results in decreased activity of and results in decreased cleavage of BID protein | CTD | PMID:12930891 |
| minocycline | multiple interactions | ISO | RGD:620160 | 6480464 | Minocycline inhibits the reaction [HTT protein mutant form results in increased cleavage of and results in increased activity of BID protein] | CTD | PMID:12930891 |
| minocycline | multiple interactions | ISO | RGD:620160 | 6480464 | [Minocycline results in increased expression of BCL2 protein] which binds to BID protein | CTD | PMID:15004018 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:1346183 | 6480464 | Acetylcysteine inhibits the reaction [cadmium acetate results in increased cleavage of BID protein] | CTD | PMID:16169029 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:1346183 | 6480464 | Acetylcysteine inhibits the reaction [cordycepin results in decreased expression of BID protein] | CTD | PMID:21310227 |
| N-acetyl-L-cysteine | multiple interactions | ISO | RGD:1346183 | 6480464 | Acetylcysteine inhibits the reaction [[Cisplatin co-treated with FASLG protein] results in decreased expression of BID protein] | CTD | PMID:17574045 |
| N-methyl-N'-nitro-N-nitrosoguanidine | multiple interactions | EXP | | 6480464 | Eugenol inhibits the reaction [Methylnitronitrosoguanidine results in decreased expression of BID mRNA] | CTD | PMID:20434464 |
| N-methyl-N'-nitro-N-nitrosoguanidine | decreases expression | EXP | | 6480464 | Methylnitronitrosoguanidine results in decreased expression of BID mRNA | CTD | PMID:20434464 |
| N-nitrosodiethylamine | affects response to substance | EXP | | 6480464 | BID protein affects the susceptibility to Diethylnitrosamine | CTD | PMID:15904428 |
| nickel dichloride | increases expression | ISO | RGD:620160 | 6480464 | nickel chloride results in increased expression of BID mRNA | CTD | PMID:21843586 |
| nickel sulfate | increases expression | ISO | RGD:1346183 | 6480464 | nickel sulfate results in increased expression of BID mRNA | CTD | PMID:16780908 |
| nimesulide | multiple interactions | ISO | RGD:1346183 | 6480464 | benzyloxycarbonyl-isoleucyl-glutamyl-threonyl-aspartic acid fluoromethyl ketone inhibits the reaction [nimesulide results in increased cleavage of and results in increased activity of BID protein] | CTD | PMID:19360361 |
| nitric oxide | increases cleavage | ISO | RGD:1346183 | 6480464 | Nitric Oxide results in increased cleavage of BID protein | CTD | PMID:15126337 |
| nitroprusside | decreases expression | ISO | RGD:620160 | 6480464 | Nitroprusside results in decreased expression of BID protein modified form | CTD | PMID:18311796 |
| nitroprusside | multiple interactions | ISO | RGD:620160 | 6480464 | cilostazol inhibits the reaction [Nitroprusside results in decreased expression of BID protein modified form]; more ... | CTD | PMID:18311796 |
| paclitaxel | increases expression | ISO | RGD:1346183 | 6480464 | Paclitaxel results in increased expression of BID protein | CTD | PMID:14749477 |
| paclitaxel | multiple interactions | ISO | RGD:1346183 | 6480464 | [Tretinoin co-treated with Paclitaxel] results in increased cleavage of BID protein | CTD | PMID:18098270 |
| paclitaxel | increases cleavage | ISO | RGD:1346183 | 6480464 | Paclitaxel results in increased cleavage of BID protein | CTD | PMID:18098270 |
| paracetamol | multiple interactions | EXP | | 6480464 | Plant Extracts inhibits the reaction [Acetaminophen results in increased expression of BID protein] | CTD | PMID:20355050 |
| paracetamol | multiple interactions | EXP | | 6480464 | [Acetaminophen co-treated with dioscin] results in increased expression of BID protein | CTD | PMID:22939915 |
| paracetamol | decreases expression | ISO | RGD:1346183 | 6480464 | Acetaminophen results in decreased expression of BID mRNA | CTD | PMID:21420995 |
| paracetamol | increases expression | EXP | | 6480464 | Acetaminophen results in increased expression of BID protein | CTD | PMID:20355050 |
| paraquat | decreases expression | ISO | RGD:1346183 | 6480464 | Paraquat results in decreased expression of BID mRNA | CTD | PMID:18836921 |
| pemetrexed | multiple interactions | ISO | RGD:1346183 | 6480464 | [Cisplatin co-treated with pemetrexed] results in increased cleavage of BID protein | CTD | PMID:19351772 |
| phenethyl isothiocyanate | multiple interactions | ISO | RGD:1346183 | 6480464 | phenethyl isothiocyanate results in increased expression of and results in increased cleavage of BID protein | CTD | PMID:16054126 |
| phylloquinone | multiple interactions | ISO | RGD:1346183 | 6480464 | [sorafenib co-treated with Vitamin K 1] results in increased cleavage of BID protein | CTD | PMID:20301194 |
| pirinixic acid | decreases expression | EXP | | 6480464 | pirinixic acid results in decreased expression of BID mRNA | CTD | PMID:18445702 |
| progesterone | decreases expression | ISO | RGD:1346183 | 6480464 | Progesterone results in decreased expression of BID mRNA | CTD | PMID:18037150 |
| propiconazole | decreases expression | EXP | | 6480464 | propiconazole results in decreased expression of BID mRNA | CTD | PMID:22334560 |
| pterostilbene | increases expression | EXP | | 6480464 | pterostilbene results in increased expression of BID protein modified form | CTD | PMID:20681671 |
| quercetin | multiple interactions | ISO | RGD:1346183 | 6480464 | Quercetin promotes the reaction [TNFSF10 protein results in increased cleavage of BID protein] | CTD | PMID:17876056 |
| quercetin | multiple interactions | ISO | RGD:1346183 | 6480464 | [arsenic trioxide co-treated with Quercetin] results in increased cleavage of BID protein | CTD | PMID:18359480 |
| resveratrol | increases cleavage | ISO | RGD:1346183 | 6480464 | resveratrol results in increased cleavage of BID protein | CTD | PMID:16617056 PMID:19423619 |
| resveratrol | multiple interactions | ISO | RGD:1346183 | 6480464 | [resveratrol results in increased activity of CASP8 protein] which results in increased cleavage of BID protein | CTD | PMID:18276737 |
| resveratrol | multiple interactions | ISO | RGD:1346183 | 6480464 | [resveratrol co-treated with TNFSF10 protein] results in increased cleavage of BID protein | CTD | PMID:20097879 |
| resveratrol | multiple interactions | ISO | RGD:1346183 | 6480464 | [TNFSF10 protein co-treated with resveratrol] results in increased cleavage of BID protein | CTD | PMID:18222423 |
| resveratrol | increases localization | ISO | RGD:1346183 | 6480464 | resveratrol results in increased localization of BID protein | CTD | PMID:19561642 |
| resveratrol | increases expression | ISO | RGD:1346183 | 6480464 | resveratrol results in increased expression of BID protein | CTD | PMID:16731767 |
| resveratrol | increases cleavage | ISO | RGD:1346183 | 6480464 | resveratrol results in increased cleavage of BID protein | CTD | PMID:16617056 |
| resveratrol | multiple interactions | ISO | RGD:1346183 | 6480464 | [resveratrol results in increased activity of CASP8 protein] which results in increased cleavage of BID protein | CTD | PMID:18276737 PMID:19423619 |
| resveratrol | decreases expression | ISO | RGD:1346183 | 6480464 | resveratrol results in decreased expression of BID protein | CTD | PMID:20717957 |
| selenium atom | increases cleavage | ISO | RGD:1346183 | 6480464 | Selenium results in increased cleavage of BID protein | CTD | PMID:12432279 |
| silibinin | affects localization | ISO | RGD:1346183 | 6480464 | silybin affects the localization of BID protein modified form | CTD | PMID:16777994 |
| silibinin | increases cleavage | ISO | RGD:1346183 | 6480464 | silybin results in increased cleavage of BID protein | CTD | PMID:16777994 |
| silibinin | multiple interactions | ISO | RGD:1346183 | 6480464 | benzoylcarbonyl-valyl-aspartyl-valyl-alanyl-aspartyl-fluoromethyl ketone inhibits the reaction [silybin results in increased cleavage of BID protein]; more ... | CTD | PMID:16777994 |
| silver atom | increases expression | ISO | RGD:1346183 | 6480464 | Silver results in increased expression of BID mRNA | CTD | PMID:21611810 |
| silver(0) | increases expression | ISO | RGD:1346183 | 6480464 | Silver results in increased expression of BID mRNA | CTD | PMID:21611810 |
| sirolimus | multiple interactions | ISO | RGD:1346183 | 6480464 | [7-hydroxystaurosporine co-treated with Sirolimus] results in increased cleavage of BID protein | CTD | PMID:15767555 |
| sirolimus | increases expression | EXP | | 6480464 | Sirolimus results in increased expression of BID mRNA; more ... | CTD | PMID:19922502 |
| sirolimus | decreases expression | EXP | | 6480464 | Sirolimus results in decreased expression of BID protein | CTD | PMID:18097008 |
| sirolimus | multiple interactions | EXP | | 6480464 | [Sirolimus results in decreased activity of RPS6KB1 protein] which results in increased expression of BID protein; more ... | CTD | PMID:19922502 |
| sodium dichromate | multiple interactions | EXP | | 6480464 | MAPK8 protein affects the reaction [sodium bichromate results in increased cleavage of BID protein]; more ... | CTD | PMID:21047991 |
| sodium dichromate | increases cleavage | EXP | | 6480464 | sodium bichromate results in increased cleavage of BID protein | CTD | PMID:20298709 PMID:21047991 |
| sodium dichromate | multiple interactions | EXP | | 6480464 | CAT protein inhibits the reaction [sodium bichromate results in increased cleavage of BID protein]; more ... | CTD | PMID:20298709 |
| sodium dichromate | increases cleavage | EXP | | 6480464 | sodium bichromate results in increased cleavage of BID protein | CTD | PMID:21047991 |
| staurosporine | increases expression | ISO | RGD:1346183 | 6480464 | Staurosporine results in increased expression of BID protein | CTD | PMID:19552762 |
| staurosporine | multiple interactions | ISO | RGD:1346183 | 6480464 | Staurosporine promotes the reaction [BID protein binds to BAX protein] | CTD | PMID:19552762 |
| sulforaphane | multiple interactions | EXP | | 6480464 | sulforafan inhibits the reaction [sulforafan results in increased expression of BID protein] | CTD | PMID:21684301 |
| sulforaphane | increases expression | EXP | | 6480464 | sulforafan results in increased expression of BID protein | CTD | PMID:21684301 |
| tamoxifen | multiple interactions | ISO | RGD:1346183 | 6480464 | [Tamoxifen co-treated with TNFSF10 protein] results in increased cleavage of BID protein | CTD | PMID:17767197 |
| taurine | decreases expression | ISO | RGD:1346183 | 6480464 | Taurine results in decreased expression of BID mRNA | CTD | PMID:16579726 |
| topotecan | affects response to substance | ISO | RGD:1346183 | 6480464 | BID protein affects the susceptibility to Topotecan | CTD | PMID:16217747 |
| topotecan | increases cleavage | EXP | | 6480464 | Topotecan results in increased cleavage of BID protein | CTD | PMID:19812371 |
| topotecan | multiple interactions | EXP | | 6480464 | APAF1 promotes the reaction [Topotecan results in increased cleavage of BID protein]; more ... | CTD | PMID:19812371 |
| trans-resveratrol | multiple interactions | ISO | RGD:1346183 | 6480464 | [resveratrol results in increased activity of CASP8 protein] which results in increased cleavage of BID protein | CTD | PMID:18276737 PMID:19423619 |
| trans-resveratrol | multiple interactions | ISO | RGD:1346183 | 6480464 | [resveratrol results in increased activity of CASP8 protein] which results in increased cleavage of BID protein | CTD | PMID:18276737 |
| trans-resveratrol | multiple interactions | ISO | RGD:1346183 | 6480464 | [resveratrol co-treated with TNFSF10 protein] results in increased cleavage of BID protein | CTD | PMID:20097879 |
| trans-resveratrol | multiple interactions | ISO | RGD:1346183 | 6480464 | [TNFSF10 protein co-treated with resveratrol] results in increased cleavage of BID protein | CTD | PMID:18222423 |
| trans-resveratrol | increases localization | ISO | RGD:1346183 | 6480464 | resveratrol results in increased localization of BID protein | CTD | PMID:19561642 |
| trans-resveratrol | increases expression | ISO | RGD:1346183 | 6480464 | resveratrol results in increased expression of BID protein | CTD | PMID:16731767 |
| trans-resveratrol | increases cleavage | ISO | RGD:1346183 | 6480464 | resveratrol results in increased cleavage of BID protein | CTD | PMID:16617056 |
| trans-resveratrol | decreases expression | ISO | RGD:1346183 | 6480464 | resveratrol results in decreased expression of BID protein | CTD | PMID:20717957 |
| trans-resveratrol | increases cleavage | ISO | RGD:1346183 | 6480464 | resveratrol results in increased cleavage of BID protein | CTD | PMID:16617056 PMID:19423619 |
| triamcinolone acetonide | increases expression | ISO | RGD:620160 | 6480464 | Triamcinolone Acetonide results in increased expression of BID protein | CTD | PMID:15987869 |
| trichostatin A | multiple interactions | ISO | RGD:1346183 | 6480464 | trichostatin A promotes the reaction [CASP9 protein affects the localization of BID protein] | CTD | PMID:12556448 |
| trimellitic anhydride | increases expression | EXP | | 6480464 | trimellitic anhydride results in increased expression of BID mRNA | CTD | PMID:19042947 |
| troglitazone | decreases expression | EXP | | 6480464 | troglitazone results in decreased expression of BID mRNA | CTD | PMID:17569031 |
| urethane | multiple interactions | EXP | | 6480464 | [Urethane co-treated with Freund's Adjuvant] results in increased expression of BID mRNA | CTD | PMID:12400877 |
| valproic acid | increases cleavage | ISO | RGD:1346183 | 6480464 | Valproic Acid results in increased cleavage of BID protein | CTD | PMID:19351772 |
| valproic acid | multiple interactions | ISO | RGD:1346183 | 6480464 | [Valproic Acid co-treated with decitabine] results in increased cleavage of BID protein | CTD | PMID:21771726 |
| zoledronic acid | increases expression | ISO | RGD:1346183 | 6480464 | zoledronic acid results in increased expression of BID mRNA | CTD | PMID:19036117 |